MedTrace Logo

Australian Hepatitis and Risk Survey in Prisons

NCT05839522 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2400

Last updated 2023-05-03

No results posted yet for this study

Summary

The Australian Hepatitis and risk survey in prisons (AusHep) is a national prison-based blood-borne virus (BBV) surveillance study. This biobehavioural survey involves point-of-care testing for hepatitis C (HCV) antibodies and RNA (if antibody positive), hepatitis B surface antigens, hepatitis B surface antibodies, and HIV surface antibodies, and an interview-style survey on prior testing and treatment history and engagement in risk behaviours. The study will recruit approximately 2400 prisoner participants from 25 representative prisons across Australia, annually.

Conditions

Interventions

DIAGNOSTIC_TEST

Point-of-care hepatitis C antibody test

Qualitative point-of-care test for hepatitis C antibodies (saliva sample)

DIAGNOSTIC_TEST

Point-of-care hepatitis C RNA test

Hepatitis C Viral Load point-of-care test (fingerstick wholeblood sample)

DIAGNOSTIC_TEST

Point-of-care hepatitis B surface antibody test

Qualitative hepatitis B surface antibody point-of-care test (fingerstick wholeblood sample)

DIAGNOSTIC_TEST

Point-of-care hepatitis B surface antigen test

Qualitative hepatitis B surface antigen point-of-care test (fingerstick wholeblood sample)

DIAGNOSTIC_TEST

Point-of-care HIV antibody test

Qualitative HIV antibody point-of-care test (saliva sample)

BEHAVIORAL

Interview-style survey

Interview-style survey regarding demographics, risk behaviours, BBV testing and treatment history, and point-of-care testing acceptability

Sponsors & Collaborators

  • Kirby Institute

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-27
Primary Completion
2023-05-01
Completion
2023-05-01

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05839522 on ClinicalTrials.gov